, India’s biggest FMCG player, is a textbook example of a high-quality compounder but recent quarters have raised questions about its growth trajectory.
What’s Going Well:
ROE improving for 3 straight years — shows efficient use of shareholder capital.
Zero debt, zero promoter pledge — financially strong and stable.
Annual EPS growth for 2 years — long-term earnings power remains intact.
DII confidence is rising, with institutional shareholding inching up.
But here’s the flip side:
Revenue, profit & margins have declined in the last two quarters — both YoY and QoQ.
Net profit down with falling margins — a sign of demand slowdown and higher input costs.
Stock trades at a high PE (>40) — leaves little room for error in performance.
FII holding has dropped, signaling some foreign investor caution
Technically:
Above 20 & 50 DMA, but below 200 DMA — mixed trend signals.
Institutional interest is stable, but market is recalibrating expectations after recent weakness.
3-Year CAGR:
Revenue: +9.6%
Net Profit: +8.7%
Operating Profit: +8.7%
This shows steady, but not spectacular, growth — especially considering HUL’s premium valuation.
Investor Takeaway:
HUL remains a core defensive stock in many portfolios. But near-term performance has been underwhelming due to rural slowdown, volume pressures, and margin compression. Investors should watch closely for recovery signs in consumption demand.
Learning Point: Even quality companies with strong balance sheets can face cyclical headwinds. Always balance valuations with earnings momentum before entering long-term positions.